Clinical Trial Update: Bioequivalence of RYTHMOL SR® Manufactured at Two Different Sites [Phase 1]

View source ↗

Summary

This Phase 1 trial assesses the bioequivalence of RYTHMOL SR when manufactured at two different sites and has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiac Arrhythmias

Drugs mentioned

• RYTHMOL SR (Propafenone hydrochloride)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Arrhythmia, Cardiac | Phase 1 | Status: COMPLETED